Apollo Hospitals Enterprise (BOM:508869) Other Current Receivables: ₹0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:508869 Apollo Hospitals Enterprise Ltd BOM:508869
94 GF Score
Price ₹8,659.00
GF Value ₹9,088.58
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Apollo Hospitals Enterprise Other Current Receivables?

Apollo Hospitals Enterprise BOM:508869 -0.70% 94 Other Current Receivables is ₹0 Mil as of Jun. 2026. GuruFocus rates BOM:508869 with a GF Score™ of 94/100 and a GF Value™ of ₹9,088.58 (Fairly Valued). The stock has 4 warning signs investors should review.

Apollo Hospitals Enterprise's Other Current Receivables for the quarter that ended in Jun. 2026 was ₹0 Mil.

Apollo Hospitals Enterprise's annual Other Current Receivables increased from Mar. 2024 (₹2,972.00 Mil) to Mar. 2025 (₹3,445.00 Mil) and increased from Mar. 2025 (₹3,445.00 Mil) to Mar. 2026 (₹3,456.00 Mil).

Apollo Hospitals Enterprise Other Current Receivables Related Terms

Apollo Hospitals Enterprise Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Apollo Hospitals Enterprise's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Apollo Hospitals Enterprise Other Current Receivables Chart

Apollo Hospitals Enterprise Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,850.00 2,637.00 2,972.00 3,445.00 3,456.00

Apollo Hospitals Enterprise Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 1,813.00 0.00 3,456.00 0.00
BOM:508869
94GF Score
Apollo Hospitals Enterprise Ltd BOM:508869
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Apollo Hospitals Enterprise Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of ₹0 Mil mean?
Apollo Hospitals Enterprise (BOM:508869) has a Other Current Receivables of ₹0 Mil as of Jun. 2026. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Apollo Hospitals Enterprise and its competitors.
Is Apollo Hospitals Enterprise's Other Current Receivables too high?
Apollo Hospitals Enterprise's current Other Current Receivables is ₹0 Mil. Overall, Apollo Hospitals Enterprise has a GF Score™ of 94/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Apollo Hospitals Enterprise's Other Current Receivables compare to HCA and THC?
Apollo Hospitals Enterprise's Other Current Receivables of ₹0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Healthcare Providers & Services company?
A good Other Current Receivables depends on the Healthcare Providers & Services industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Apollo Hospitals Enterprise and its competitors. Apollo Hospitals Enterprise's current Other Current Receivables is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Apollo Hospitals Enterprise stock overvalued right now?
Based on GuruFocus' analysis, Apollo Hospitals Enterprise (BOM:508869) is currently considered Fairly Valued. The stock's GF Value™ is ₹9,088.58, compared to a current price of ₹8,659.00 — trading 4.7% below its estimated fair value. The current Other Current Receivables is ₹0 Mil. Apollo Hospitals Enterprise's overall GF Score™ is 94/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Apollo Hospitals Enterprise (BOM:508869), the current Other Current Receivables is ₹0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Apollo Hospitals Enterprise (BOM:508869) Overvalued in 2026?

Based on GuruFocus' analysis, Apollo Hospitals Enterprise stock appears to be undervalued. The current stock price of ₹8,659.00 is trading 4.7% below its estimated GF Value™ of ₹9,088.58. GuruFocus considers Apollo Hospitals Enterprise to be Fairly Valued.

Key valuation signals for BOM:508869:

  • Other Current Receivables: ₹0 Mil
  • GF Value™: ₹9,088.58 vs. price of ₹8,659.00 (4.7% below fair value)
  • GF Score™: 94/100 with 4 warning signs

No single metric tells the full story. See the BOM:508869 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Apollo Hospitals Enterprise Business Description

Other Exchanges APOLLOHOSP:India
Address No. 8-17, Shafee Mohammed Road, Sunny Side Building, East Block, 3rd Floor, Chennai, TN, IND, 600006
Apollo Hospitals Enterprise Ltd operates a network of private hospitals in India through primary, secondary, and tertiary care facilities. The firm's tertiary care hospitals provide complex care in a variety of specialties that include cardiology, oncology, neuroscience, orthopedics, radiology, and gastroenterology. Apollo Hospitals also operates primary care and diagnostics clinics as well as telemedicine units and offers consulting, health insurance, education and training, and research services. Its reportable operating segments are; Healthcare Services (represents hospitals and hospitals services); Retail Health and Diagnostics (includes clinics and diagnostics); Digital Health and Pharmacy Distribution; and Others. Maximum revenue is generated from its Healthcare Services segment.
94GF Score

Get the complete analysis for BOM:508869

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹8,659.00
Price
₹9,088.58
GF Value